About NU Therapeutics
NU Therapeutics is a company based in Hyderabad (India) founded in 2010 was acquired by Shilpa Medicare in July 2011.. NU Therapeutics operates in a competitive market with competitors including Lyndra, i2o Therapeutics, Biora Therapeutics, Cure Pharmaceutical and Cingulate, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Shilpa Medicare
(Jul 19, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NU Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NU Therapeutics
NU Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Shilpa Medicare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs, fine chemicals, intermediates, and formulations are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NU Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NU Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nu Therapeutics Comparisons
Competitors of NU Therapeutics
NU Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyndra, i2o Therapeutics, Biora Therapeutics, Cure Pharmaceutical and Cingulate, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovates long-acting oral therapies to simplify patient medication regimens.
|
|
| domain | founded_year | HQ Location |
Oral drug delivery solutions are provided via liquid technology platform.
|
|
| domain | founded_year | HQ Location |
Smart pills are developed for targeted gastrointestinal drug delivery.
|
|
| domain | founded_year | HQ Location |
Oral thin film-based drug delivery systems are developed.
|
|
| domain | founded_year | HQ Location |
Cingulate is focused on developing treatments for ADHD and anxiety.
|
|
| domain | founded_year | HQ Location |
Oral drug delivery systems for individualized micro-unit dosing are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NU Therapeutics
When was NU Therapeutics founded?
NU Therapeutics was founded in 2010.
Where is NU Therapeutics located?
NU Therapeutics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
What does NU Therapeutics do?
NU Therapeutics was established in 2010 in Hyderabad, India. Pharmaceutical formulations are created, with emphasis on oral fast-dissolving thin strip technology for drug delivery. Operations center on biotechnology and pharmaceuticals, where innovative dosage forms are explored to enhance medication administration. The company is led by Managing Director Venkatesh Katakam, and activities remain based in the Indian market.
Who are the top competitors of NU Therapeutics?
NU Therapeutics's top competitors include i2o Therapeutics, Cingulate and Cure Pharmaceutical.
Who are NU Therapeutics's investors?
NU Therapeutics has 1 investor. Key investors include Shilpa Medicare.